Article
Intercellular CRISPR Screens Enhance the Discovery of Cancer Immunotherapy Targets
2022-03-04
Abstract excerpt
Cancer immunotherapy works through the interplay between immune and cancer cells. Particularly, interactions between cytotoxic T lymphocytes (CTLs) and cancer cells, such as PDCD1 (PD-1) and CD274 (PD-L1), are crucial for removing cancer cells. However, immune checkpoint inhibitors targeting these interactions are effective only to a subset of patients, requiring the development of novel immunotherapy drugs with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 702348c4-841d-533d-b265-4c18a11b3e92
- DOI
- 10.1101/2022.03.03.482805
